| 股东名称 | 咸持方式 | 减持期间 | 减持股数(股) | 占公司总股 本比例(%) | | --- | --- | --- | --- | --- | | 邹伟民 | 集中竞价 | 2025. 06. 04 | 1,112,800 | 0. 38% | | | 大宗交易 | 2025. 05. 29- | 2,223,717 | 0.77% | | 格通创投 | 集中竞价 | | 882,200 | 0. 30% | | | 大宗交易 | | 3,564,597 | 1.23% | | 陈敏 | | | - | 0. 00% | | | 合计 | | 7.783.314 | 2. 69% | 中国经济网北京6月6日讯传艺科技（002866）(002866.SZ)昨日晚间披露关于控股股东、实际控制人及其一致行动人持股比例变动触及1%及 5%整数倍暨披露简式权益变动报告书的提示性公告。 公司近日收到控股股东、实际控制人邹伟民及其一致行动人宁波格通创业投资合伙企业(有限合伙)以下简称("格通创投")出具的《简式权益 变动报告书》及《股份减持告知函》，获悉邹伟民及其一致行动人格通创投于2025年5月29日至6 ...

中信证券股份有限公司、中泰证券股份有限公司 关于乖宝宠物食品集团股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 中信证券股份有限公司（以下简称"中信证券"）、中泰证券股份有限公司 （以下简称"中泰证券"）受乖宝宠物食品集团股份有限公司（以下简称"乖宝 宠物"）股东 Golden Prosperity Investment S.A.R.L.（以下简称"出让方"）委托， 组织实施本次乖宝宠物首发前股东向特定机构投资者询价转让（以下简称"本次 询价转让"）。 根据《上市公司股东减持股份管理暂行办法》《深圳证券交易所创业板股票 上市规则（2025 年修订）》《深圳证券交易所上市公司自律监管指引第 18 号— —股东及董事、高级管理人员减持股份（2025 年修订）》《深圳证券交易所上市 公司自律监管指引第 16 号——创业板上市公司股东询价和配售方式转让股份 （2025 年修订）》（以下简称"《询价转让和配售指引》"）等相关规定，中信 证券、中泰证券对参与本次询价转让股东的相关资格进行核查，并出具本核查意 见。 一、本次询价转让的委托 中信证券、中泰证券收到出让方关于本次询价转让的委托，委托中信证券 ...

Group 1 - The company, Lifan Pharmaceutical (stock code 003020), announced that several key personnel and shareholders plan to reduce their holdings in the company [1] - Board member Wang Qing intends to reduce his holdings by no more than 321,200 shares, accounting for 0.17% of the company's total share capital [1] - Supervisor Wang Qin plans to reduce his holdings by no more than 143,400 shares, representing 0.07% of the total share capital [1] - Senior management member Dai Tianhe aims to reduce his holdings by no more than 142,900 shares, also 0.07% of the total share capital [1] - Senior management member Zheng Yong plans to reduce his holdings by no more than 104,100 shares, which is 0.05% of the total share capital [1] - Shareholder Gao Meihua intends to reduce his holdings by no more than 300,000 shares, accounting for 0.16% of the total share capital [1] Group 2 - The reduction period for these shareholdings is set from June 30, 2025, to September 29, 2025, and from June 12, 2025, to September 11, 2025 [1] - The method of reduction will be through centralized bidding or block trading [1]

Core Viewpoint - The announcement reveals that Chen Rongfa, a director and senior executive of Sifang Jingchuang (300468), plans to reduce his shareholding in the company due to personal financial needs, involving a maximum of 276,300 shares, which represents 0.05% of the total share capital [1] Summary by Relevant Sections - **Shareholding Reduction Plan** - Chen Rongfa intends to reduce his holdings by up to 276,300 shares within three months following the announcement, through centralized bidding [1] - This reduction accounts for 0.05% of the company's total share capital [1] - **Reason for Reduction** - The reason for the share reduction is stated as personal financial needs [1] - **Source of Shares** - The shares to be reduced are sourced from the equity incentive plan granted to Chen Rongfa [1] - **Compliance and Disclosure** - Chen Rongfa will strictly adhere to relevant laws and regulations during the reduction process and will fulfill information disclosure obligations in a timely manner [1]

Core Viewpoint - The announcement details a significant share reduction by a major shareholder of Tuoxin Pharmaceutical, indicating a shift in ownership structure and potential implications for investor confidence [1][2]. Shareholding Changes - The controlling shareholder, Yang Xining, and his concerted action party, Yiwos Trading Co., Ltd., reduced their stake by 1,019,100 shares, representing 0.81% of the total share capital [1][2]. - Post-reduction, the combined shareholding of Yang Xining and Yiwos decreased from 28.80% to 27.99% [1]. Financial Performance - Tuoxin Pharmaceutical reported a revenue of 422 million yuan for the previous year, a decline of 49.53% year-on-year [2]. - The net profit attributable to shareholders was -19.88 million yuan, compared to a profit of 243 million yuan in the previous year [2]. - The net profit after deducting non-recurring gains and losses was -27.26 million yuan, down from 23.2 million yuan year-on-year [2]. - The net cash flow from operating activities was 103 million yuan, an increase of 280.91% year-on-year [2]. Recent Quarterly Results - In the first quarter of 2025, Tuoxin Pharmaceutical achieved a revenue of 96.99 million yuan, a decrease of 10.46% compared to the same period last year [3]. - The net profit attributable to shareholders was -3.56 million yuan, compared to a profit of 0.21 million yuan in the same quarter last year [3]. - The net cash flow from operating activities was 28.01 million yuan, a decline of 153.72% year-on-year [3]. Dividend Distribution - The board approved a profit distribution plan, proposing no cash dividends or stock bonuses for shareholders [3]. Initial Public Offering (IPO) Details - Tuoxin Pharmaceutical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on October 27, 2021, with an initial public offering of 31.5 million shares at a price of 19.11 yuan per share [3]. - The total funds raised amounted to 602 million yuan, with a net amount of 543 million yuan after deducting issuance costs [3][4]. - The funds were intended for projects related to nucleoside series specialty raw materials, pharmaceutical intermediates, and working capital [3].

Core Viewpoint - Qingniao Fire Protection (002960.SZ) announced the completion of its shareholder's share reduction plan, with the controlling shareholder Beijing Peking University Qingniao Huan Yu Technology Co., Ltd. reducing 20 million shares within the specified period [1] Shareholder Reduction Details - The reduction was executed through concentrated bidding and block trading methods, with the total shares reduced amounting to 2,000,000 shares, representing a 2.72% reduction of the total shares [2] - The average reduction price was 11.23 CNY per share for 700,000 shares, 12.13 CNY for 1,146,800 shares, and 10.23 CNY for 153,200 shares [2] Financial Impact - The total cash generated from the share reduction was approximately 23,338,920 CNY [3] - Qingniao Fire Protection was listed on the Shenzhen Stock Exchange on August 9, 2019, with an initial public offering of 60 million shares at a price of 17.34 CNY per share, raising a total of 104,040,000 CNY [3] - The company conducted a private placement of 74,422,182 shares on November 3, 2022, at a price of 24.01 CNY per share, raising approximately 1,786,876,589.82 CNY [3] Profit Distribution Plans - For the 2021 fiscal year, the company proposed a cash dividend of 4.0 CNY per 10 shares, totaling 139,574,244.40 CNY, along with a capital reserve conversion increasing the total shares to 488,509,855 [4] - In 2020, the company distributed 4.489534 CNY per 10 shares in cash and converted capital reserves to increase shares by 3.990697 per 10 shares [4]

Group 1 - Company X plans to purchase servers worth up to 4 billion yuan for providing computing power leasing services, which accounts for over 50% of its latest audited net assets and total assets, requiring shareholder approval [2] - Company Y's stock has experienced a significant increase of 46.44% over four consecutive trading days, with its cultural and creative business showing considerable unpredictability, projecting revenues of 8.868 million yuan, 5.417 million yuan, and 18.462 million yuan for the years 2022 to 2024 respectively [3] - Company Z's chairman has resigned due to personal reasons, and the vice chairman will temporarily assume the chairman's responsibilities until a new chairman is elected [4] Group 2 - Shareholder of Company A intends to reduce their stake by up to 3%, equating to a maximum of 1.6 million shares [5] - Company B's controlling shareholder has committed not to reduce their holdings from May 30, 2025, to December 31, 2025, including any shares resulting from capital increases or stock dividends during this period [6] - Company C plans to repurchase shares worth between 10 million and 20 million yuan for an employee stock ownership plan, with a maximum repurchase price of 43 yuan per share [7]

Group 1 - The core point of the news is that Wald (688028.SH) announced a share reduction plan by its shareholders due to personal financial needs, which may impact the company's stock performance [1] - Shareholder Chen Tao plans to reduce up to 300,000 shares, accounting for no more than 0.20% of the total share capital [1] - Shareholder Li Qinghua intends to reduce up to 200,000 shares, representing no more than 0.13% of the total share capital [1] - Shareholder Peng Kun aims to reduce up to 412,104 shares, which is no more than 0.27% of the total share capital [1] - The reduction period for the shares will be implemented within three months after the announcement, starting 15 trading days post-announcement [1] Group 2 - Wald was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 22, 2019, with an issuance of 20 million shares at a price of 26.68 yuan per share [2] - The total amount raised from the issuance was 533.60 million yuan, with a net amount of 469.27 million yuan after deducting issuance costs, which was 61.99 million yuan less than originally planned [2] - The funds raised were intended for several projects, including ultra-high precision tool industrialization upgrades and working capital [2][3] Group 3 - The investment budget for the ultra-high precision tool industrialization upgrade project is 165.62 million yuan, with a construction period of 2 years [3] - The high precision tool industrialization upgrade project has a budget of 121.48 million yuan, also with a 2-year construction period [3] - The high precision tool expansion project has a budget of 35.55 million yuan, with a 1-year construction period [3] - The total investment for all projects listed is 407.29 million yuan [3] Group 4 - In a previous transaction, Wald planned to acquire 100% equity of Xinjinquan for 696.50 million yuan, with the equity being evaluated at 703.32 million yuan [4] - The company issued shares to raise matching funds totaling approximately 486.95 million yuan, which is not more than the total transaction price [4] - The number of shares issued for this transaction was 14,163,757 shares at a price of 34.38 yuan per share [4] Group 5 - The total amount raised by Wald from two fundraising rounds is approximately 1.02 billion yuan [6] - The company announced a profit distribution plan, distributing a cash dividend of 0.30 yuan per share and a capital reserve conversion of 0.40 shares per share, resulting in a total share capital increase [6]

Core Viewpoint - The announcement details the shareholding structure and the planned share reduction by significant shareholders of Beijing World Diamond Tools Co., Ltd, indicating a potential liquidity event for the company [1][2][3]. Shareholding Structure - As of the announcement date, shareholder Chen Tao holds 933,800 shares (0.61% of total shares), shareholder Li Qinghua holds 502,236 shares (0.33%), and shareholder Peng Kun holds 412,104 shares (0.27%). These shareholders are considered concerted actors of actual controllers Chen Jifeng and Yang Nuo [1][2][3]. Reduction Plan Details - The shareholders plan to reduce their holdings as follows: - Chen Tao: Up to 300,000 shares (0.20% of total shares) [3][4]. - Li Qinghua: Up to 200,000 shares (0.13% of total shares) [3][4]. - Peng Kun: Up to 412,104 shares (0.27% of total shares) [3][4]. - The reduction will occur through centralized bidding from June 19, 2025, to September 18, 2025 [3][4]. Shareholding Source and Reason for Reduction - All shares intended for reduction were acquired before the IPO, and the reason for the reduction is personal funding needs [3][4]. Previous Reduction Activities - The last reduction activities by the concerted actors included: - Chen Tao reduced 66,402 shares (0.06%) between August 24, 2022, and November 30, 2022, at prices ranging from 39.59 to 49.60 yuan per share [3]. - Peng Kun reduced 19,500 shares (0.02%) during the same period at prices between 40.73 and 41.18 yuan per share [3]. Compliance and Commitments - The planned reductions are consistent with previous commitments made by the shareholders regarding their shareholding behavior post-IPO, ensuring compliance with relevant regulations [4].

Core Points - The report indicates that Xinjiang Jiangzhiyuan Equity Investment Partnership (Limited Partnership) has reduced its shareholding in Yaqi International Investment (Guangzhou) Co., Ltd. to 5% [1][6][9] - The reduction in shareholding was due to the need to withhold personal income tax for its partners, leading to a decrease in shareholding from 5.02% to 5.00% [5][7][9] - The share reduction occurred through centralized bidding from May 22, 2025, to May 23, 2025, totaling 213,177 shares, which represents 0.02% of the total share capital [6][9][10] Summary by Sections Section 1: Definition - Yaqi International refers to Yaqi International Investment (Guangzhou) Co., Ltd. [4] - The information disclosing party is Xinjiang Jiangzhiyuan Equity Investment Partnership (Limited Partnership) [4] Section 2: Information Disclosing Party Introduction - Xinjiang Jiangzhiyuan was established on December 2, 2010, with a registered capital of 30 million RMB [5] - The partnership is managed by Shanghai Hongce Private Fund Management Co., Ltd. [5] Section 3: Purpose of Equity Change - The equity change was necessary for the information disclosing party to comply with tax obligations [5][7] Section 4: Equity Change Method - The equity change was executed through centralized bidding, resulting in a reduction of 213,177 shares [6][9] Section 5: Recent Trading Activity - The information disclosing party did not increase its holdings in the past six months and only reduced shares through bidding [10] Section 6: Other Significant Matters - The report confirms that there are no misleading statements or omissions regarding the equity change [2][10]